Itau Unibanco Holding S.A.’s Bio-Rad Laboratories Class A BIO Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.6K	Sell	203 -1	-0.5%	-$284	﹤0.01%	276
2026 Q1	$56.9K	Buy	204 +7	+4%	+$2.02K	﹤0.01%	236
2025 Q4	$59.7K	Buy	197 +72	+58%	+$22.5K	﹤0.01%	226
2025 Q3	$35K	Hold	125	–	–	﹤0.01%	286
2025 Q2	$30.2K	Sell	125 -2	-2%	-$473	﹤0.01%	310
2025 Q1	$31K	Buy	+127	New	+$38.2K	﹤0.01%	324
2024 Q3	–	Sell	-11	Closed	-$3K	–	343
2024 Q2	$3K	Buy	+11	New	+$3.2K	﹤0.01%	334
2024 Q1	–	Sell	-38	Closed	-$12.3K	–	155
2023 Q4	$12.3K	Sell	38 -9	-19%	-$2.82K	﹤0.01%	307
2023 Q3	$16.8K	Sell	47 -1	-2%	-$386	﹤0.01%	385
2023 Q2	$18.2K	Sell	48 -113	-70%	-$46K	﹤0.01%	430
2023 Q1	$77.1K	Buy	+161	New	+$75.4K	﹤0.01%	288
2021 Q4	–	Sell	-29	Closed	-$22K	–	411
2021 Q3	$22K	Buy	29 +1	+4%	+$749	﹤0.01%	328
2021 Q2	$18K	Buy	+28	New	+$17K	﹤0.01%	305
2018 Q2	–	Sell	-263	Closed	-$66K	–	751
2018 Q1	$66K	Buy	+263	New	+$67K	﹤0.01%	458

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Itau Unibanco Holding S.A.'s BIO Position: Q2 2026 in Review

Itau Unibanco Holding S.A. reduced its Bio-Rad Laboratories Class A (BIO) stake by 0.49% in Q2 2026, selling an estimated $284 and leaving 203 shares worth $59.6K. The position accounts for ﹤0.01% of the portfolio, ranked #276.

Itau Unibanco Holding S.A. first reported a position in BIO in Q1 2018 and has held it in 14 quarters since. The position peaked at $77.1K in Q1 2023. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

Itau Unibanco Holding S.A. held 203 shares of Bio-Rad Laboratories Class A worth $59.6K as of Q2 2026.
Itau Unibanco Holding S.A. sold 1 Bio-Rad Laboratories Class A share in Q2 2026, an estimated $284.
Bio-Rad Laboratories Class A made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q2 2026, its #276 holding.
Itau Unibanco Holding S.A. first reported a position in Bio-Rad Laboratories Class A in Q1 2018 and has held it in 14 quarters since.
Itau Unibanco Holding S.A.'s Bio-Rad Laboratories Class A position peaked at $77.1K in Q1 2023.
399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q2 2026, filed 14 Aug 2026.